Cite
HARVARD Citation
Heald, A. et al. (2021). Comparing cost of intravenous infusion and subcutaneous biologics in COVID‐19 pandemic care pathways for rheumatoid arthritis and inflammatory bowel disease: A brief UK stakeholder survey. International journal of clinical practice. 75 (9), p. n/a. [Online].